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STUDY QUESTION: Are there age-related differences in gene expression during the germinal vesicle (GV) to metaphase II (MII) stage
transition in euploid human oocytes?
SUMMARY ANSWER: A decrease in mitochondrial-related transcripts from GV to MII oocytes was observed, with a much greater re-
duction in MII oocytes with advanced age.
WHAT IS KNOWN ALREADY: Early embryonic development is dependent on maternal transcripts accumulated and stored within the
oocyte during oogenesis. Transcriptional activity of the oocyte, which dictates its ultimate developmental potential, may be influenced by
age and explain the reduced competence of advanced maternal age (AMA) oocytes compared with the young maternal age (YMA). Gene
expression has been studied in human and animal oocytes; however, RNA sequencing could provide further insights into the transcriptome
profiling of GV and in vivo matured MII euploid oocytes of YMA and AMA patients.
STUDY DESIGN, SIZE, DURATION: Fifteen women treated for infertility in a single IVF unit agreed to participate in this study. Five
GV and 5 MII oocytes from 6, 21–26 years old women (YMA cohort) and 5 GV and 6 MII oocytes from 6, 41–44 years old women (AMA
cohort) undergoing IVF treatment were donated. The samples were collected within a time frame of 4 months. RNA was isolated and
deep sequenced at the single-cell level. All donors provided either GV or MII oocytes.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Cumulus dissection from donated oocytes was performed 38 h after hCG in-
jection, denuded oocytes were inserted into lysis buffer supplemented with RNase inhibitor. The samples were stored at 80C until fur-
ther use. Isolated RNA from GV and MII oocytes underwent library preparation using an oligo deoxy-thymidine (dT) priming approach
(SMART-Seq v4 Ultra Low Input RNA assay; Takara Bio, Japan) and Nextera XT DNA library preparation assay (Illumina, USA) followed
by deep sequencing. Data processing, quality assessment and bioinformatics analysis were performed using source-software, mainly includ-
ing FastQC, HISAT2, StringTie and edgeR, along with functional annotation analysis, while scploid R package was employed to determine
the ploidy status.
MAIN RESULTS AND THE ROLE OF CHANCE: Following deep sequencing of single GV and MII oocytes in both YMA and AMA
cohorts, several hundred transcripts were found to be expressed at significantly different levels. When YMA and AMA MII oocyte tran-
scriptomes were compared, the most significant of these were related to mitochondrial structure and function, including biological pro-
cesses, mitochondrial respiratory chain complex I assembly and mitochondrial translational termination (false discovery rate (FDR) 6.0E10
to 1.2E7). These results indicate a higher energy potential of the YMA MII cohort that is reduced with ageing. Other biological processes
that were significantly higher in the YMA MII cohort included transcripts involved in the translation process (FDR 1.9E2). Lack of these
transcripts could lead to inappropriate protein synthesis prior to or upon fertilisation of the AMA MII oocytes.
LARGE SCALE DATA: The RNA sequencing data were deposited in the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/
geo), under the accession number: GSE164371.
LIMITATIONS, REASONS FOR CAUTION: The relatively small sample size could be a reason for caution. However, the RNA se-
quencing results showed homogeneous clustering with low intra-group variation and five to six biological replicates derived from at least
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three different women per group minimised the potential impact of the sample size.
WIDER IMPLICATIONS OF THE FINDINGS: Understanding the effects of ageing on the oocyte transcriptome could highlight the
mechanisms involved in GV to MII transition and identify biomarkers that characterise good MII oocyte quality. This knowledge has the po-
tential to guide IVF regimes for AMA patients.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the Medical Research Council (MRC Grant number
MR/K020501/1).
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Introduction
Reproductive ageing is an irreversible biological process that occurs in
advance of senescence. Oocyte developmental competence (quality)
and fertility rates are reduced upon ageing (Navot et al., 1991). It is
widely accepted that increasing chromosome segregation errors lead
to significantly higher frequencies of chromosome anomalies, elevated
miscarriage rates with advanced age and a significant decrease in preg-
nancy rate (Duncan et al., 2012; Webster and Schuh, 2017; Gruhn
et al., 2019). Other underlying factors that may contribute to reduced
oocyte quality with age include the transcriptional activity of the oo-
cyte, which may dictate the developmental potential of the oocyte and
the embryo (Song and Wessel, 2005; Stitzel and Seydoux, 2007), along
with factors involved in mitochondrial functionality, including mitochon-
drial gene expression and energy production (Schatten et al., 2014).
Early embryonic cleavage, for example, is governed by maternal
RNA stores that accumulate within the oocyte during oogenesis
(Cimadomo et al., 2018). Alterations in the mRNA and proteins in the
cytoplasm of advanced maternal age (AMA) oocytes and early em-
bryos could therefore partially explain the aetiology of infertility in
AMA women (Hamatani et al., 2004). Genes expressed in the oocyte
are dramatically degraded upon the transition from the immature ger-
minal vesicles (GVs) to the mature/fertile metaphase II (MII) oocyte in
mammals (Su et al., 2007; Reyes et al., 2017). These transcripts are
probably important during oogenesis, but may be unnecessary in the fi-
nal MII oocyte growth phase, while other transcripts are involved in
protein synthesis, relying on a combination of the poly(A) tail length
and high affinity RNA binding proteins (Kim et al., 2011).
Gene transcripts present in oocytes are mainly involved in meiosis-
related processes, as well as energy production and metabolism. Gene
expression associated with signalling pathways, appears to be quite sta-
ble in the late growth phase of the oocytes, indicating their highly im-
portant role in oocyte maturation (Su et al., 2007; Reyes et al., 2017).
Oocyte maturation is modulated by a highly regulated programme of
gene expression, along with cytoplasmic deadenylation (Reyes et al.,
2015). Ageing, however, does not appear to affect GV and MII oocyte
gene expression equally, with the latter reporting a much greater
number of significantly altered gene transcripts with ageing. Overall,
changes in oocyte mitochondrial number and activity combined with
epigenetic modifications of the oocyte and altered DNA methylation
patterns caused by advancing maternal age, may impact on the health
of the offspring (Tarı́n et al., 2002; Liang et al., 2008, 2011; Khan et al.,
2016).
Different studies have investigated the transcriptome derived from
mammalian GV and MII oocytes. These studies revealed pathways as-
sociated with the ageing process and the transition from GV to MII
oocytes, including the study by that used human GV oocytes and
in vitro matured (IVM) MII oocytes to investigate the response of young
maternal age (YMA; <30 years) and AMA (40 years) oocytes to
in vitro matured. To the best of our knowledge, our study is the first
to investigate the impact of ageing on the transcriptome of individual
euploid human oocytes upon the transition of the immature GV to the
in vivo matured MII oocyte. The YMA MII oocytes are associated with
the greatest potential for successful embryo development. This means
that differences identified between the GV and MII oocyte stages and
different maternal ages, could improve our understanding of subse-
quent successful human embryo development and suggest potential
molecular biomarkers that are indicative of high oocyte quality.
Materials and methods
Ethical approval
Women presented for infertility treatment at the Reproductive
Medicine Unit, Genesis Athens Clinic, Greece, between September
and December 2017. All women were eligible to participate in this
study. The study was approved by the National Health System A’
Administration of the Health District of Attica, General Children
Hospital ‘Aghia Sofia’ (19964/04-09-2014) and the Greek National
Authority of Assisted Reproduction. Women participating in the cur-
rent study provided signed informed consent for oocyte donation. All
women were recruited from a single IVF unit.
Sample recruitment and treatment
Fifteen women treated for infertility agreed to participate in this study.
Five GV and 5 MII oocytes from 6 women (21–26 years old; YMA co-
hort) and 5 GV and 6 MII oocytes from 6 women (41–44 years old;
AMA cohort) undergoing IVF treatment were donated. The samples
were collected within a time frame of 4 months and RNA was isolated
and deep sequenced at the single-cell level. Ovarian stimulation was
performed according to a short, step down GnRH agonist stimulation
protocol with a recombinant FSH (folitropin alpha) (Gonal-F; Merck
Serono Europe Ltd., Germany) starting on the second day of the men-
strual cycle for final follicular maturation and were followed by oocyte
retrieval guided by ultrasound. Doses varied according to women’s’
age and individual infertility profile (range 150–300 IU/day). All women
were re-evaluated on Day 5 of stimulation with a transvaginal ultra-
sound examination and serum oestradiol levels. At this time, adjust-
ments to the dose were made. Triggering was performed with
recombinant hCG (Ovitrelle, Merck Serono Europe Ltd., Germany)
36 h prior to transvaginal oocyte collection. Following oocyte collec-
tion, cumulus dissection with hyaluronidase (FertiPro, Belgium) from


































































































donated oocytes was performed 38 h after hCG administration.
Denuded oocytes were assessed for maturation stage and transferred
into lysis buffer supplemented with RNase inhibitor.
RNA isolation, library construction and
deep sequencing
The SMART-Seq v4 Ultra Low Input RNA method (Takara Bio, Japan)
was employed for library construction, according to the manufacturer’s
instructions. Following two washing steps in calcium/magnesium free
Dulbecco’s Phosphate Buffered Saline (Merck Serono, Germany), the
oocytes from all the four cohorts were immediately transferred into
the lysis buffer with RNase Inhibitor (Takara Bio, Japan) and frozen at
80C until required. The first cDNA strand was synthesised using
the locked nucleic acid technology and large quantities of full-length
cDNA were produced by long-distance PCR. The same number of
PCR cycles (16 cycles) were applied to keep constant conditions
across the samples. The amplified cDNA was purified by the
Agencourt Ampure XP Beads (Beckman Coulter, USA).
Amplified full-length cDNA quantification employed a high sensitivity
fluorometric assay (Qubit) (Thermo Fisher Scientific, USA) with 150 pg
being processed further using Illumina’s Nextera XT DNA library con-
struction method according to the manufacturer’s instructions
(Illumina, USA). Tagging and fragmentation of the full-length cDNA oc-
curred in a single step and a unique combination of i7 and i5 indices
per library was used (Illumina, USA). Amplified libraries were purified
by Agencourt AMPure XP beads (Beckman Coulter, USA). A high
sensitivity fluorometric assay (Qubit) was employed using Qubit 1.0
fluorometer (Thermo Fisher Scientific, USA) together with the 2100
Bioanalyzer system (Agilent Technologies, USA) for evaluating oocyte
quantity and quality, respectively. The average length distribution of
the fragmented cDNA was calculated using the high sensitivity DNA
assay (Agilent, USA), followed by equimolar pooling and deep RNA
sequencing (150 base pairs) on a HiSeq 3000 (Illumina, USA).
Bioinformatics analysis
Sequence quality was assessed using FastQC (Andrews, 2010). Trim ga-
lore was employed for automated adapter and quality trimming
(Krueger, 2015). Reads passing Quality Control (QC) were mapped to
the human reference genome (hg38) by the HISAT2 aligner v2.0.4
(Pertea et al., 2016). Samtools v1.3 was used to remove unpaired and
unmapped reads (Li et al., 2009) and PCR duplicates were tagged by
Picard tools v2.1.1 (Broad Institute (2010). Available online at http://
broadinstitute.github.io/picard). StringTie was employed to detect po-
tentially novel transcripts using UCSC hg38 RefSeq annotation of the hu-
man transcriptome as a guide (Pertea et al., 2015). To assign and
quantify reads mapping to known and predicted transcripts and to
cross-check the robustness of differential gene expression (DGE) detec-
tion, two approaches were used. The first employed a python script
(available online: http://ccb.jhu.edu/software/stringtie/dl/prepDE.py)
to extract read counts from the HISAT2/StringTie outputs in a format
suitable as input for the Bioconductor/R package edgeR (Robinson and
Oshlack, 2010; R Core Team, 2013). The other used the
featureCounts function of Rsubread to generate count tables (Liao
et al., 2013). Both long coding and long non-coding transcripts were
revealed through this approach.
The DaMiRseq R package pipeline was employed to determine mo-
lecular biomarkers that could characterise the quality of YMA and AMA
oocytes (Chiesa et al., 2018). A correlation cut off of 0.3 was used for
normalisation and partial least-square feature selection (FSelect function)
to consider gene expression in at least half of the samples of the smaller
cohort (i.e. YMA oocytes). We selected the number of surrogate varia-
bles that explained at least 90% of the variation. Default values were
used for all other functions. Pheatmap and ggplot2 R packages were
employed to generate distance matrix and multi-dimensional scaling
plots (Kolde and Kolde, 2015; Wickham, 2016).
Statistical analysis
The thresholds for transcript inclusion in the DGE analysis were at
least one counts-per-million reads (cpm) present in at least four sam-
ples. The calcNormFactors function was used to normalise count data,
according to the trimmed mean M value (Robinson and Oshlack,
2010). Gene transcripts represented at significantly different levels
among the oocyte cohorts were detected using the generalised linear
model (GLM) approach with false discovery rate (FDR) threshold set
at 0.05 and fold change greater than 2 (Robinson and Oshlack, 2010).
Functional annotation, aneuploidy analysis
and meta-analysis
Ontological analysis of differentially expressed genes was conducted by
DAVID (Huang et al., 2009) and goana function in R (Young et al.,
2010), including the significantly up-regulated gene transcripts of the
YMA and AMA GV and/or MII oocytes. We mainly focused on the bi-
ological processes, cellular components and Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway analyses. FDR was employed
for DGE and ontological analysis. The R package scploid, developed by
Griffiths et al. (2017), was employed to determine the ploidy status
from YMA and AMA GV and MII oocytes. The RNA sequencing data
were deposited in the Gene Expression Omnibus (GEO) (https://
www.ncbi.nlm.nih.gov/geo), under the GEO accession number:
GSE164371. The current study also considered RNA sequencing data
from GV and in vitro matured MII oocytes that were derived from
young and advanced age women in the context of meta-analysis (GEO
accession: GSE95477).
RNA sequencing validation by qRT-PCR
SMART-Seq v4 ultra-low input RNA method (Takara-Clontech, USA)
was employed to validate the RNA-Seq results that derived from
single GV and MII oocytes. In brief, reverse transcription was followed
by long distance PCR to generate sufficient quantities of cDNA librar-
ies per oocyte. Roche LC480 thermal cycler (Roche, Switzerland) was
then used to perform quantitative real-time PCR (qRT-PCR) on three
replicates. Annealing temperature was always set at 60C
(Supplementary Table SI). Normalisation was conducted using H3F3B,
GAPDH, HNRNPC and ACTB genes as endogenous controls. Gene
expression differences between the oocyte groups were calculated
using the 2DDCt method (Livak and Schmittgen, 2001).

















































































To investigate the molecular transcriptome dynamics involved in ma-
ternal ageing, individual GV and in vivo matured MII oocytes were ana-
lysed by RNA sequencing from YMA (<30 years old) and AMA
(>40 years old) groups. Fifteen women treated for infertility in a single
IVF unit agreed to participate in this study by donating oocytes. The
mean (SD) ages of the women consisting the YMA GV and MII groups
were 22.6 (2.3) years and 21.6 (1.5) years, respectively. The average
(SD) age of the women consisting the AMA GV and MII groups were
42.8 (1.1) years and 42 (1.0) years, respectively (Table I). Samples
were collected within a 4-month time frame. No morphological differ-




Following library construction and deep sequencing of each oocyte
transcriptome, the average aligned reads were 41 (9) and 38 (6)
(mean (SD)) millions for the YMA GV and MII oocytes, respectively,
and 31 (3) and 30 (5) million reads for the GV and MII oocytes of
AMA (Supplementary Table SII). The main genes discussed in this
study showed a statistical dispersion of 0.17 and a minimum fold
change per comparison of 2.5. Aneuploidy analysis relying on the RNA
sequencing data considered only euploid oocytes to participate in the
current study. A euploid GV with a normal score range between 0.8
and 1.2 is shown as example (Fig. 1).
The transcriptome relationships among the four oocyte cohorts
were illustrated using a distance matrix, which was generated based
on sample-by-sample correlation, highlighting specific clusters related
to maternal age (Fig. 2). Unlike the YMA and AMA MII oocytes that
resulted in separate clusters following hierarchical clustering, the YMA
and AMA, GV oocytes did not show a distinct separation relying on
maternal age, which indicates that ageing has a greater effect on the fi-
nal stage of oocyte differentiation (MII oocytes).
Unsupervised multidimensional scaling plot illustrated oocyte tran-
scriptomes classified based on their developmental stage and maternal
age (Fig. 3). GV oocytes are shown on the left side of the diagram
with the MII oocytes on the right side. A clear separation between the
two developmental stages is illustrated. YMA and AMA GV oocyte
transcriptomes lie close with each other sharing an extended overlap.
This is also supported by the previous unclear separation of the GV
oocytes shown in Fig. 2. A clear transcriptome separation is depicted
in the YMA and AMA MII oocytes, indicating a higher number of dif-
ferentially expressed transcript between the two groups. GV and MII
oocytes showed better separation according to the first dimension
(X axis), while alterations in both dimensions (dimensions 1 and 2)
seem to play a role when ageing is considered (Fig. 3).
The effect of ageing and developmental
stage on the oocyte gene expression
To reveal the genes involved in the ageing process that could play a
role in the reduced developmental potential, we investigated the DGE
levels of the oocyte cohorts, which were classified based on the ma-
ternal age (YMA/AMA) and oocyte developmental stage (GV/MII).
The transcriptome relationships among the four oocyte cohorts were
assessed using edgeR, along with the ontological enrichment per co-
hort. No enriched gene ontologies were revealed when YMA and
AMA GV oocytes were compared, although individual DGE genes
were involved among others in oocyte metabolism (QDPR) and ubiq-
uitin-dependent degradation (FBXO32) (Supplementary Table SIII).
These gene expression alterations could illustrate minor differences in
the GV oocyte energy production and/or utilisation with ageing.
A much greater effect was revealed at the MII oocyte stage, with
1080 genes being significantly higher expressed in the YMA and 111 in
the AMA oocytes (Supplementary Table SIV). Although no particular
ontologies were significantly enriched in the AMA MII oocytes accord-
ing to DAVID ontological analysis, the YMA MII oocytes were signifi-
cantly enriched for mitochondria-related biological processes, including
mitochondrial respiratory chain complex I assembly (FDR 4.0E10) and
mitochondrial translational elongation (FDR 3.3E08). These results
were confirmed by the cellular component analysis, with the top gene
ontologies including mitochondrial inner membrane (FDR 1.3E16) and
mitochondrion (FDR 6.2E14). Among other mitochondrial-related
ontologies, the extracellular exosome ontology was significantly more
highly enriched (FDR 9.6E07). This ontology consisted of 194 genes
or 19% of the total number of genes that were significantly more
highly expressed in the YMA MII oocytes (Table II). These outcomes
are also supported by the ontological analysis performed by goana R
package to the YMA and AMA MII oocytes (Fig. 4). Mitochondrial, ox-
idoreductase activity and translational/post-translational ontological
terms were reported, along with the chromatin organisation. The lat-
ter could reflect the transition of the nuclear architecture/chromatin
structure with ageing, compromising perhaps the developmental po-
tential of the AMA oocytes (Ge et al., 2015; Sun et al., 2018). This
process may coincide with the meiotic transcription differences with
ageing, due to epigenetic alterations (Navarro-Costa et al., 2016).
............................................................................................................................................................................................................................
Table I Characteristics of GV and MII oocyte patients.
GV YMA MII YMA GV AMA MII AMA
Mean age § SD per
oocyte
22.6§ 2.3 21.6§ 1.5 42.8§ 1.1 42§ 1.0
Number of women 4 4 4 3
Number of oocytes 5 5 5 7
Infertility factor No (donor) No (donor) Unexplained/AMA Male/AMA
AMA, advanced maternal age; GV oocyte, germinal vesicle oocyte; MII oocyte, metaphase II oocyte; YMA, young maternal age.










































..When the fold change was set at 2.5, the comparison between dif-
ferent oocyte developmental stages revealed 4681 genes up-regulated
in GV YMA and 857 in the MII YMA oocytes. In the AMA oocytes,
6159 genes were up-regulated in the GV and 1368 in the MII cohort.
DGE analysis of the GV oocyte transcriptomes with regards to the
maternal age, revealed only two up-regulated transcripts, SFXN5 and
LINC01755, in the YMA and eight gene transcripts higher in the AMA
oocytes, including among others CDA, SLC35A1, NPL, FBXO32 and
FGFR2. Unlike the GV oocytes, the MII revealed more differentially
expressed genes, with 1080 being up-regulated in the YMA and 111 in
the AMA cohort, illustrating a potentially different effect of ageing in
the GV to MII oocytes (Table III).
Focusing on the developmental stages, a higher total number of
genes is expressed in the GV compared with the MII oocytes, irre-
spectively of the maternal age (Supplementary Table SV). The YMA
GV oocytes generally include ontologies enriched for mitochondria
and mitochondrial translation (FDR 9.6E6 to 5.1E3), proteasome-
mediated ubiquitin-dependent degradation (FDR 3.6E3) and mRNA
splicing (FDR 3.7E3). Among the higher enriched cellular components
in the YMA GV oocytes, were mitochondrion and mitochondrial inner
membrane ontologies with FDR 2.8E16 and 5.7E15, respectively,
suggesting that the human GV oocytes express more mitochondrial-
related transcripts than the MII oocytes. The YMA MII oocytes
showed more highly expressed genes involved in biological processes
associated with the preparation of the oocyte for fertilisation and early
embryo development. The main biological processes include among
others cell and nuclear division (FDR 2.1E10 to 8.5E5), cell–cell ad-
hesion (FDR 3.9E7), RNA metabolism, splicing and post-transcription
modifications (FDR 8.4E9 to 9.3E3). The majority of the significantly
higher expressed MII genes are localised in the nucleoplasm of the MII
oocytes with high confidence (FDR 3.1E56).
When the AMA oocyte gene transcripts are considered, the biologi-
cal processes enriched for up-regulated AMA GV transcripts include
mitochondrial-related ontologies (FDR 8.6E15 to 1.2E2), along with
alternative splicing (FDR 2.4E5), proteasome-dependent degradation
(FDR 2.1E4 to 1.5E2) and vesicle-mediated transport (FDR 3.7E3
to 3.6E2). These AMA GV transcripts are mainly localised in mito-
chondria and the inner mitochondrial membrane with high confidence,
reporting FDR of 4.5E35 and 1.1E32, respectively (Supplementary
Table SVI). The transcripts up-regulated in the AMA MII oocytes were
involved in cell division and cell cycle-related ontologies resulting in


































range: 0.8 − 1.2
Figure 1. Bell shaped histograms illustrate the score of the average euploid GV and MII oocytes. Normal scores generated by scploid
software range between 0.8 and 1.2 (euploidy status). Based on the allele specific gene expression, a score of 1 indicates that no aneuploid chromo-
somes were present. The results derived from the RNA sequencing data analysis. AMA, advanced maternal age; GV oocyte, germinal vesicle oocyte;
MII oocyte, metaphase II oocyte; YMA, young maternal age.












































adhesion is another significantly enriched ontology in the AMA MII
oocytes, with other significant ontologies including DNA repair (FDR
6.9E12), post-transcription regulation ontologies such as alternative
splicing, mRNA export from nucleus, mRNA 30-end processing (FDR
3.8E8–1.5E3), post-translational regulation, including ubiquitin-de-
pendent degradation (FDR 5.1E8–2.4E3).
DGE analysis of the RNA-Seq data provided potential molecular
biomarkers for subsequent validation by qRT-PCR. RNF123 is an E3
ubiquitin ligase that reported six times higher levels of expression in
the MII AMA compared with the MII YMA oocytes (Supplementary
Fig. S1). Extracellular exosome-related genes could be good quality
markers of MII oocytes with higher likelihood of successful fertilisation.
For example, the extracellular-exosome-related gene transcripts CD74
and CD9 were approximately between 4 and 15 times more highly
expressed in the MII YMA compared with the MII AMA oocytes
(Supplementary Fig. S1), while in some of the MII AMA oocytes the
expression levels were extremely low. RAB43 (or RAB11B) belongs to
the RAB family and was approximately five times more highly
expressed in the MII YMA compared with the MII AMA oocytes.
RAB43 is another member of the RAB family that was expressed ap-
proximately 4 times higher in the MII YMA compared with the GV
YMA oocytes, indicating the importance of this family for the MII YMA
group. Finally, the chaperone HSPA6 and the chaperone-like RSAD1,
showed a gene expression spectrum from extremely low to almost no
expression in the MII YMA oocytes, with significantly higher expression
in the GV YMA oocytes. Both the RNA-Seq and qRT-PCR methods
showed a good correspondence in the expression levels of the investi-
gated transcripts (Supplementary Fig. S1).
Ageing-related transcriptome alterations
during the GV to MII oocyte transition
To investigate the effect of ageing on the GV to MII oocyte transition,
we compared the differences of the differentially expressed genes be-
tween YMA and AMA cohorts. The majority of these genes (4665)
were not affected by ageing (Supplementary Fig. S2). However, a
higher number of genes were significantly differentially expressed in the
AMA GV/MII transition (2862 genes) compared with the YMA GV/
MII transition (873 genes). Considering that AMA MII oocytes corre-
spond to decreased fertilisation rate and lower embryo development
success, it is possible that the lower number of YMA transcripts upon






























































































































Figure 2. Heatmap with colours highlighting the distance matrix (Spearman’s correlation). Colour gradient ranges from dark green
(minimum distance) to light green. Horizontal bars (on the top of heatmap) represent the maternal age class. Cluster identification is facilitated by the
two dendrograms. AMA, advanced maternal age; GV oocyte, germinal vesicle oocyte; MII oocyte, metaphase II oocyte; YMA, young maternal age.












































progression through oogenesis and/or meiotic resumption, unlike the
AMA MII oocytes that potentially show a more dysregulated form of
expression. Considering that all the GV oocytes showed quite similar
gene expression patterns regardless of age, the DGE is more indicative
of age effects on the GV/MII transition than on oogenesis per se.
The transcripts that were up-regulated exclusively in the MII oocytes
upon the YMA GV/MII transition were not involved in any significant
gene ontology, although trends for certain ontologies were noted
(Supplementary Table SVII). To better understand the importance of
these transcriptome patterns, the genes that were expressed signifi-
cantly more highly, exclusively in the AMA GV/MII transition, were
split based on the oocyte developmental stage. The MII oocyte tran-
scripts with exclusive high gene expression in the AMA GV/MII transi-
tion showed a significant enrichment for nucleus and nucleoplasm
cellular components. The AMA genes more highly expressed exclu-
sively in GV oocytes, illustrated a high enrichment in several
mitochondrial-related biological processes, including mitochondrial
electron transport NADH to ubiquinone (FDR 5.1E5), mitochondrial
respiratory chain complex I assembly (FDR 4.4E4), along with cellular
components involved in mitochondria and mitochondrial inner mem-
brane with FDR of 3.9E9 and 4.4E9, accordingly (Supplementary
Table SVII). As a consequence, these ontologies were significantly
down-regulated in the AMA MII oocytes, suggesting that they could
play a key role in the decreased oocyte capacity for successful fertilisa-
tion and early developmental potential with advancing age.
Molecular biomarkers delineating the effect
of ageing on the quality of the MII oocytes
DaMiRseq package in R (Chiesa et al., 2018) was also employed to re-
fine and highlight informative molecular markers that would allow us to
increase our confidence in predicting oocyte quality. Read normalisation,
filtering and identification of surrogate variables were used to minimise
unwanted variation, with a heatmap being generated using Spearman’s
correlation, which illustrate the gene expression relationships among
cohorts (Fig. 2). This approach used the partial least squares to elimi-
nate class-related features when investigating the transcriptome from
the YMA and AMA MII oocytes and resulted in 175 highly important
gene features using the FSelect function (Supplementary Table SVIII). To
identify a smaller subset of representative gene features that could suc-
cessfully represent the YMA and AMA MII oocyte groups, DaMirSeq












































Figure 3. MDS plot illustrating GV and MII oocytes of YMA and AMA categories. The samples are coloured according to the maternal
age and the developmental stage of the oocytes. AMA, advanced maternal age; GV oocyte, germinal vesicle oocyte; MDS, multidimensional scaling;
MII oocyte, metaphase II oocyte; YMA, young maternal age.



























































representative biomarkers for each MII oocyte group by excluding the
higher correlated genes. Only 14 features were selected using this ap-
proach (Fig. 5). These gene features could further support our attempt
to classify random oocytes according to their quality, as this was guided
by the gene expression patterns of the YMA and AMA oocytes. This
methodological approach showed an overlap of 141 (81%) gene fea-
tures with the edgeR DGE analysis, when the FSelect function was
employed. The YMA oocytes express genes that could separate them
from the AMA oocytes, including the actin-related LIMCH1 and MTSS1
that may be involved in cell migration, along with the TIMP1 metallopro-
tease that among other functions it is involved in regulating cellular apo-
ptosis, which may contribute to the higher survival rates of YMA
oocytes. Histone HIST1H2AA (or H2AC1) could be accumulated in
the AMA oocytes, being potentially involved in chromatin organisation
(Stefanelli et al., 2018).
Discussion
The current study employed deep RNA sequencing on YMA and
AMA oocytes to reveal the effect of ageing upon the final phase of eu-
ploid oocyte maturation in vivo, with a focus on the MII oocytes. This
could be invaluable for women undergoing ART, suggesting potential
molecular targets that could be used to identify good quality oocytes
of greater embryonic development potential. Further to the in vitro
matured MII oocytes that participated in the study b, we employed
GV and in vivo matured MII oocytes and only analysed oocytes of eu-
ploid status, to reflect more accurately the naturally occurring condi-
tions during the late phase of meiotic progression with ageing. The
current study reflects results of a study powered at 0.7, given a 2.5-
fold change.
While the expression levels of thousands of gene transcripts
remained stable upon GV to MII transition, hundreds of transcripts
were significantly differentially expressed, highlighting molecular signa-
tures characteristic for each cell type. The MII oocytes are transcrip-
tionally silent and protein synthesis occurs on the existing transcribed
genes in the MII oocyte reserve, whereas GV oocytes are transcrip-
tionally active and, if necessary, they could replace important degrad-
ing/recycled gene transcripts (Tesarı́k et al., 1983; Bouniol-Baly et al.,
1999). This could partially explain the fact that gene expression pat-
terns between YMA and AMA GV oocytes are quite similar (10 DGE
genes), while MII oocytes showed hundreds of differentially expressed
genes between YMA and AMA groups (1191 gene transcripts).
The in vivo matured oocytes illustrated lower statistical dispersion
compared with the in vitro matured MII oocytes studied by . This may
indicate potential differences between the molecular processes in-
volved in in vivo and in vitro oocyte differentiation. For example, the
last phase of differentiation may involve a smoother and more targeted
homogeneous GV to MII transition when oocyte maturation occurs in
the female reproductive system. Taking into account the whole tran-
scriptome, ageing has probably a greater effect in in vivo and in vitro
matured MII compared with the GV oocytes, potentially compromising
successful MII oocyte and embryo development of AMA women.
Finally, inclusion of samples without chromosomal abnormalities, may
reduce gene expression variability and increase perhaps the statistical
power. Taken together, our findings suggest that the late phase of the
GV to MII oocyte transition is likely a sensitive process, highly affected
by the maternal age, potentially due to increased cellular stress and ac-
cumulated mutations induced as maternal age increases.
During GV to MII oocyte transition, 5538 genes were differentially
expressed in the YMA and 7527 in the AMA, respectively, illustrating
a 36% increase in the number of differentially expressed genes of the
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Table II Illustrates the enriched gene ontology terms of the genes significantly higher expressed in the YMA MII compared
with the AMA MII oocytes.
Gene ontology Term Count % P-value FDR
BP Mitochondrial respiratory chain complex I assembly 22 2.2 2.3E13 4.0E10
BP Mitochondrial translational elongation 23 2.3 1.9E11 3.3E8
BP Mitochondrial electron transport, NADH to ubiquinone 18 1.8 2.1E11 3.8E8
BP Mitochondrial translational termination 22 2.2 1.8E10 3.1E7
BP Translation 28 2.8 3.6E5 6.4E2
BP ER to Golgi vesicle-mediated transport 20 2.0 1.2E4 2.2E1
Gene ontology Term Count % P-value FDR
CC Mitochondrial inner membrane 70 6.9 8.7E20 1.3E16
CC Mitochondrion 130 12.8 4.2E17 6.2E14
CC Mitochondrial large ribosomal subunit 19 1.9 1.1E12 1.6E9
CC Mitochondrial respiratory chain complex I 18 1.8 2.1E11 3.0E8
CC Extracellular exosome 194 19.1 6.6E10 9.6E7
CC Mitochondrial matrix 38 3.7 3.1E7 4.5E4
CC Cytosol 200 19.7 9.1E6 1.3E2
CC Mitochondrial intermembrane space 14 1.4 2.5E5 3.7E2
The number of genes, along with the corresponding P-value and FDR are also reported. The fold-change of the differentially expressed genes has been set at 2.5.
AMA, advanced maternal age; BP, biological process; CC, cellular component; FDR, false discovery rate; MII oocyte; YMA, young maternal age.






















..AMA oocytes. Age-induced transcriptome alterations may derive from
the dysregulation of gene expression and mRNA instability (Borbolis
and Syntichaki, 2015), and could be associated with decreased fertilisa-
tion and embryo development rates (Tan et al., 2014; Cimadomo
et al., 2018). Furthermore, our study detected 8.5% of differentially
expressed gene transcripts (2.5-fold change) upon ageing, which is
5% in mice (Hamatani et al., 2004). These mouse genes are involved
in mitochondrial activity and oxidative stress responses, genome
stability, chromatin structure and DNA methylation (Hamatani et al.,
2004), with similar molecular processes reported in human
(Steuerwald et al., 2007).
The polyadenylated transcripts of this study reported similar abun-
dance in the GV oocytes irrespectively of maternal age. The AMA GV
to MII transition of the euploid human oocytes, showed a greater re-
duction in mitochondrial-related gene transcripts, compared with the
YMA oocytes. A similar observation was made in bovine oocytes
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Figure 4. Heatmap illustrating MII YMA and AMA oocyte classification. Colour gradient ranges from dark blue to yellow. Horizontal
bars (on the top of heatmap) represent the maternal age class of the oocytes MII YMA (purple) and MII AMA (orange). Ontological cluster identifica-
tion is facilitated by the dendrogram (left). The ontological term and the type of the ontology terms are illustrated on the right. AMA, advanced ma-
ternal age; BP, biological process; CC, cellular component; FC, fold change; GO, gene ontology; MF, molecular function; MII oocyte, metaphase II
oocyte; YMA, young maternal age.
............................................................................................................................................................................................................................
Table III Illustrates the differentially expressed genes between GV and MII oocytes upon ageing.
VS GV YMA (down) MII YMA (down) GV AMA (down) MII AMA (down)
GV YMA (up) – 4681 2 –
MII YMA (up) 857 – – 1080
GV AMA (up) 8 – – 6159
MII AMA (up) – 111 1358 –
The number of up-regulated genes (up) in the different oocyte stages are shown in the first column and the corresponding down-regulated (down) cohorts are shown in the first row
(down).
AMA, advanced maternal age; GV, germinal vesicle; MII oocyte; YMA, young maternal age.










































..upon GV to MII transition with ageing, including mitochondrial-related
transcripts, involved in energy-related pathways and mitochondrial or-
ganisation ontologies (Reyes et al., 2015). This could reflect a lower
need for mitochondrial protein synthesis at the MII oocyte stage as
the maximum number of mitochondria is reached following the burst
of mitochondrial replication associated with oocyte meiotic matura-
tion, with the mitochondrial levels remaining stable during preimplanta-
tion embryo development (Cotterill et al., 2013; Tsai and John, 2016).
Oxidative phosphorylation and mitochondrial dysfunction were among
the processes enriched in the down-regulated transcripts upon GV to
in vitro matured MII transition , while in the current study the reduction
of mitochondrial-related ontologies was strongly associated with suc-
cessful GV to MII transition.
The ability of an oocyte to complete meiotic maturation, fertilisation
and support early embryo development depends on the mitochondrial
number, function and energy production (Reynier et al., 2001;
Cummins, 2004; Santos et al., 2006; May-Panloup et al., 2016).
According to our study, despite the significant reduction of
mitochondrial-related gene expression levels reported in the GV to
MII oocyte transition, the YMA MII oocytes maintained significantly
higher levels compared with the AMA MII oocytes, potentially affecting
mitochondrial activity, through a gradual alteration of the mitochondrial
membrane potential associated with ageing (Wilding et al., 2001). The
maximum respiratory capacity of the aged oocytes is significantly re-
duced (Sugimura et al., 2012). Reduced ATP production leads to de-
creased metabolic activity and could affect fertilisation, embryo
development and implantation (Dumollard et al., 2007, 2007; Van
Blerkom, 2011; Eichenlaub-Ritter, 2012).
The YMA and AMA GV oocytes reported similar gene expression
levels and together with the MII oocytes provided further insights into
the oocyte quality. Several gene transcripts were reported in the MII
oocyte YMA and AMA DGE analysis, with the majority being signifi-
cantly up-regulated in the YMA (1080) compared with only 111 genes
in the AMA oocytes. Our outcomes indicate dysregulation of gene ex-
pression upon ageing, including, for example, peroxiredoxins and cyto-
chrome c oxidases. The Peroxiredoxin-1, PRDX1, has been significantly
higher expressed (>2.5 fold-change) in the YMA group. Down-regula-
tion of PRDX1 with ageing, indicates reduced oocyte protection against
oxidative stress (Kang et al., 1998). Members of the peroxiredoxin gene
family, including PRDX2, PRDX4 and PRDX6, were also higher expressed
in the YMA oocytes, indicating AMA oocyte vulnerability to oxidative



































































Figure 5. DaMiRseq analysis using the 14 features revealed by the FReduct function. Heatmap with colours highlighting MII YMA and
AMA oocytes classification (class). Colour gradient ranges from dark green to red. Horizontal bars (on the top of heatmap) represent the maternal
age group. Cluster identification is facilitated by the two dendrograms. AMA, advanced maternal age; MII oocyte, metaphase II oocyte; YMA, young
maternal age.


































































































(Mihalas et al., 2017; Sasaki et al., 2019). KEGG pathway analysis
revealed 31 genes significantly more highly expressed in the YMA
oocytes involved in oxidative phosphorylation (FDR 1.2E9),
including cytochrome c oxidases (COX gene family), such as
COX5A, COX7B, COX11, COX17, COX8A, COX8C and COX14, and
indicating the importance of this family in energy production
and potential effects in MII oocyte physiology and developmental
potential (Lord and Aitken, 2013).
Our cellular component analysis revealed 194 genes of the extracellu-
lar exosome ontology (FDR 7.0E8), significantly more highly expressed
in the YMA oocytes, including CD44, CD74, CD320 and CD9 that were
significantly more highly expressed in the YMA oocytes. CD9 is a tetra-
spanin protein normally used as exosomal marker and CD9-deficient
mouse oocytes do not properly fuse with sperm during fertilisation (Le
Naour et al., 2000), suggesting that CD9 gene expression (which was
five times lower in the AMA oocytes), could be a critical factor associ-
ated with the low fertilisation rate in AMA patients. Similarly, RAB
GTPases, including RAB1A, RAB1B, RAB43 (or RAB11B) and RAB11A, act
as coordinators of vesicular trafficking (Stenmark, 2009), with RAB11 be-
ing one of the few important genes that promote exosome biogenesis
and secretion (Blanc and Vidal, 2018). It has been shown that exosomes
are transferred from the oocyte prior to sperm-oocyte interaction/fer-
tilisation, potentially inducing the acrosome reaction (Barraud-Lange
et al., 2007; Siciliano et al., 2008; Barraud-Lange et al., 2012). Our study
suggests that the reduced fertilisation rate observed when conventional
insemination is used over ICSI in AMA women (Farhi et al., 2019),
could be partially explained by the significantly lower exosome-related
transcripts reported in AMA oocytes.
Our pipeline also considered the DaMiRseq methodological
approach that could identify molecular targets characterising
oocyte quality, potentially in the context of tag-probe labelling for
live imaging of the oocyte plasma membrane or exosomal proteins
(Yano and Matsuzaki, 2009). For example, the AMA membrane-
associated protein ABCA1 that could be involved in ABCA1-
mediated cholesterol secretion pathway (Marcil et al., 1999), and/
or the YMA membrane-associated KCNB1 and SLC9B2; may
indicate easier targets for a diagnostics approach. KCNB1 is a Kþ
channel that could regulate exocytosis (Albrecht et al., 1993),
while SLC9B2 is Naþ/Hþ antiporter involved in clathrin-mediated
endocytosis (Sneitz et al., 2009).
This is the first study that considered the impact of ageing on the
transcriptome changes of euploid GV to in vivo matured MII oocytes,
revealing various ontologies indicative of the oocyte physiology.
Considering that YMA MII oocytes are associated with the highest de-
velopmental potential, we focused on the YMA GV to MII oocyte
transition, and most importantly the differences between YMA and
AMA MII oocytes, revealing factors that could affect fertilisation and
early embryo development (Ntostis et al., 2021), supporting also the
idea that ICSI is advantageous in AMA women. Using additional meth-
odological approaches, we attempted to confirm our findings and po-
tentially revealed molecular biomarkers that could be used to
characterise oocyte quality.
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